Stage III NSCLC RWE in Chinese Patients

Clinical trial NCT04023812 · COMPLETED

Trial details

NCT number: NCT04023812
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2019-07-16
Primary completion: 2024-02-29
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.